A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-92123 (Clinical Trial 318704)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy318704.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
San Diego |
|
State:
|
|
CA |
| Zip Code: |
|
92123 |
| Conditions: |
|
Anemia - Chronic Kidney Disease |
| Purpose: |
|
This study will evaluate the efficacy and safety of intravenous MK2578, given as maintenance
treatment for renal anemia in chronic kidney disease patients on dialysis who were
previously receiving erythropoietin stimulating agents.
|
| Study summary: |
|
This study consists of a 12-week base study (MK2578-003-00) and an optional 40-week
extension study (MK2578-003-10). Patients who complete 12 weeks of treatment in the base
study will enter the extension on the most recent dose administered in the base study or a
newly adjusted dose, if adjustment is required to bring hemoglobin (Hb) levels within range.
Patients' doses of MK2578 will be adjusted upward or downward during the extension study to
maintain Hb in the range of 10-12 g/dL. |
| Criteria: |
|
Inclusion Criteria:
- Base Study:
- Patient is male or is a female who either cannot have children or who agrees to
use appropriate contraceptive measures
- Patient has been on hemodialysis for at least 6 months when informed consent is
signed
- patient has received intravenous epoetin alfa or epoetin beta for a least 6
months when the informed consent is signed
- Extension Study:
- Patient completed the base study through Week 12
- Patient tolerated MK2578 and demonstrated compliance with study procedures
Exclusion Criteria:
- Patient has a life expectancy of less than 6 months
- Patient is scheduled for a kidney transplant within the next 6 months
- Patient has had a blood transfusion within 12 weeks of screening
- Patient has had major surgery within 12 weeks of screening or plans to have surgery
- Patient has HIV
- Patient has history of blood dyscrasia, hematologic disorders or any other disease
known to cause anemia
- Patient has severe congestive heart failure
- Patient has a history of malignant cancer, except certain skin or cervical cancers
- Patient has a history of grand mal seizures within the last 6 months |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|